Medall Healthcare is among India’s largest integrated radiology and pathology companies. It is the 5th largest diagnostic company across India and #1 in South India, by revenue. Incubated by Indian private equity fund, Peepul Capital, since 2009, the company has grown at a revenue and EBITDA CAGR over FY12-18 at 24% and 43%, respectively. Medall Healthcare offers 900+ pathology tests and 750+ radiology tests and commands a network of 26 Apex labs and 160 distributed labs.
Constellation Alpha Capital acquired 93% of Medall at closing, remaining share to be acquired in June 2019. This is the largest acquisition in the Indian diagnostics sector.